Greenwoods Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Greenwoods Asset Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-27,450	Closed	-$4.73M	–	28
2018 Q3	$4.73M	Hold	27,450	–	–	0.46%	15
2018 Q2	$4.22M	Sell	27,450 -22,650	-45%	-$4.04M	0.38%	14
2018 Q1	$8.42M	Sell	50,100 -10,900	-18%	-$1.48M	0.69%	12
2017 Q4	$5.96M	Buy	+61,000	New	+$5.58M	0.5%	12
2017 Q2	–	Sell	-36,000	Closed	-$1.32M	–	26
2017 Q1	$1.32M	Hold	36,000	–	–	0.14%	20
2016 Q4	$1.09M	Buy	+36,000	New	+$1.13M	0.13%	21

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Greenwoods Asset Management's ONC Position: Q4 2018 in Review

Greenwoods Asset Management sold out of BeOne Medicines Ltd (ONC) in Q4 2018, closing a stake of 27,450 shares — an estimated $4.73M sold.

Greenwoods Asset Management first reported a position in ONC in Q4 2016 and held it in 6 quarters. The position peaked at $8.42M in Q1 2018. 192 funds tracked by Wall St. Rank hold ONC as of Q4 2018.

Greenwoods Asset Management reported no remaining BeOne Medicines Ltd position as of Q4 2018 after selling out during the quarter.
Greenwoods Asset Management sold 27,450 BeOne Medicines Ltd shares in Q4 2018, an estimated $4.73M.
Greenwoods Asset Management first reported a position in BeOne Medicines Ltd in Q4 2016 and held it in 6 quarters.
Greenwoods Asset Management's BeOne Medicines Ltd position peaked at $8.42M in Q1 2018.
192 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2018.

Based on Greenwoods Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.